These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37278215)

  • 1. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
    Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
    Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
    JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
    Mills JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis.
    Motta LS; Gosmann NP; Costa MA; Jaeger MB; Frozi J; Grevet LT; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum G
    BMJ Ment Health; 2023 Feb; 26(1):. PubMed ID: 37142305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
    Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
    CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials.
    Wang L; Tobe J; Au E; Tran C; Jomy J; Oparin Y; Couban RJ; Paul J
    Br J Anaesth; 2022 Jan; 128(1):118-134. PubMed ID: 34756632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
    Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
    Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
    Sobieraj DM; Martinez BK; Hernandez AV; Coleman CI; Ross JS; Berg KM; Steffens DC; Baker WL
    J Am Geriatr Soc; 2019 Aug; 67(8):1571-1581. PubMed ID: 31140587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.
    Wang Z; Whiteside SPH; Sim L; Farah W; Morrow AS; Alsawas M; Barrionuevo P; Tello M; Asi N; Beuschel B; Daraz L; Almasri J; Zaiem F; Larrea-Mantilla L; Ponce OJ; LeBlanc A; Prokop LJ; Murad MH
    JAMA Pediatr; 2017 Nov; 171(11):1049-1056. PubMed ID: 28859190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
    Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE
    Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.
    Chawla N; Anothaisintawee T; Charoenrungrueangchai K; Thaipisuttikul P; McKay GJ; Attia J; Thakkinstian A
    BMJ; 2022 Jan; 376():e066084. PubMed ID: 35045991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
    Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
    Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
    Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
    Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
    Khanassov V; Hu J; Reeves D; van Marwijk H
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.